US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

iShares Biotechnology ETF

208.95

-5.8500-2.72%

Pre-market: 208.93-0.0200-0.01%07:06 EDT

Volume:1.42M

Turnover:298.43M

Market Cap:10.52B

PE:33.10

High:213.89

Open:213.10

Low:208.54

Close:214.80

52wk High:217.12

52wk Low:138.79

Shares:50.35M

Float Shares:50.35M

Volume Ratio:0.88

T/O Rate:2.82%

Dividend:0.42

Dividend Rate:0.20%

EPS(TTM):6.31

EPS(LYR):-1.4940

ROE:24.54%

ROA:0.10%

PB:1.29

PE(LYR):-139.86

Loading ...

Overview Company News Filings

Renalytix Discloses Director’s Link to Trellus Administration as KidneyIntelX Rollout Advances

Political and General News Events from August 24

Exchange-Traded Funds, Equity Futures Fall Pre-Bell Monday as Investors Await Details on US Sanctions Against Iran

MT Newswires Live

Morning Movers: Regenxbio sinks following clinical hold on RGX-121

Sector Update: Healthcare

MT Newswires Live

Liminatus Pharma Engages Synex as Contract Research Organization to Support Phase 1/2a Clinical Development of CD19xCD22 bivalent CAR-T therapy

Regenxbio reports FDA placed clinical hold on RGX-121

EU Commission Approves Gilead Trodelvy-Keytruda Combo for First-Line PD-L1+ Metastatic TNBC

Gilead - EU Grants Marketing Authorization for Trodelvy with Keytruda in First-Line Pd-L1-Positive Metastatic Tnbc

THOMSON REUTERS

European Commission Expands Role of Gilead’s Trodelvy® in First-Line Metastatic Triple-Negative Breast Cancer Across Pd-L1 Status

THOMSON REUTERS

Analysts Are Bullish on Top Healthcare Stocks: Enliven Therapeutics (ELVN), Argenx Se (ARGX)

Daiichi Sankyo Names Ken Keller Chief Commercialization Officer, Effective April 2027

Is Viavi Solutions (VIAV) Quietly Recasting Its 6G Moat With the Vertex 6.0 Launch?

Simply Wall St.

ETF Weekly | ETHU Jumps 62%; NUGT Climbs 29%; SMST, MSTZ Sink 45%; Crypto Leverage Sets the Pace

Regeneron Pharmaceuticals (REGN) Wins Pasatru Approval, Is The Upside Already Priced In?

Simply Wall St.

Funds: What a Top Biotech Fund is Buying Now

Gilead Director Jeffrey Bluestone Disposes of 5,000 Common Shares Worth $727,333.60

Moderna Inc. Stock Advances 8.9%, Outperforms Peers

Gilead Declares Q3 2026 Dividend of R$ 0.24 Per Unit

Amgen Advances Tarlatamab Shot vs. Infusion in Phase 3 Lung Cancer Study

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://sg.tigeractivity.com/stock/IBB/news?page=5"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"IBB","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"IBB\",,,,,undefined,":{"symbol":"IBB","market":"US","secType":"STK","nameCN":"iShares Biotechnology ETF","latestPrice":208.95,"timestamp":1787947200000,"preClose":214.8,"halted":0,"volume":1420692,"hourTrading":{"tag":"盘前","latestPrice":208.93,"preClose":208.95,"latestTime":"07:06 EDT","volume":210,"amount":43785.8274,"timestamp":1788174412064,"change":-0.02,"changeRate":-0.000096,"amplitude":0.007681},"delay":0,"changeRate":-0.027234636871508483,"floatShares":50350000,"shares":50350000,"eps":6.311863,"marketStatus":"Pre-Mkt","change":-5.85,"latestTime":"08-31 07:31:23 EDT","open":213.095,"high":213.89,"low":208.54,"amount":298428416.27508,"amplitude":0.024907,"askPrice":212.5,"askSize":20,"bidPrice":208.13,"bidSize":1,"shortable":3,"etf":1,"ttmEps":6.311863,"tradingStatus":1,"nextMarketStatus":{"tag":"Open","tradingStatus":2,"beginTime":1788183000000},"marketStatusCode":1,"adr":0,"adrRate":0,"exchange":"NASDAQ","adjPreClose":208.95,"sharesOutstanding":49450000,"nav":208.979543,"aum":10469875104.3,"dividendRate":0.002,"bidAskSpread":0.000356,"preHourTrading":{"tag":"盘前","latestPrice":208.93,"preClose":208.95,"latestTime":"07:06 EDT","volume":210,"amount":43785.8274,"timestamp":1788174412064,"change":-0.02,"changeRate":-0.000096,"amplitude":0.007681},"postHourTrading":{"tag":"盘后","latestPrice":208.5,"preClose":208.95,"latestTime":"19:56 EDT","volume":19496,"amount":4073588.5582,"timestamp":1787961384780,"change":-0.45,"changeRate":-0.002154,"amplitude":0.002154},"volumeRatio":0.8819865165205065,"impliedVol":0.2419,"impliedVolPercentile":0.648},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"IBB\",,,,,undefined,":{"symbol":"IBB","floatShares":50350000,"roa":"0.10%","roe":"24.54%","lyrEps":-1.493977,"volumeRatio":0.8819865165205065,"shares":50350000,"dividePrice":0.4179,"high":213.89,"amplitude":0.024907,"preClose":214.8,"low":208.54,"week52Low":138.785,"pbRate":"1.29","psRate":"253.12","week52High":217.12,"institutionHeld":0,"latestPrice":208.95,"committee":-0.904762,"eps":6.311863,"divideRate":0.002,"volume":1420692,"delay":0,"ttmEps":6.311863,"open":213.095,"prevYearClose":168.77,"prevWeekClose":208.95,"prevMonthClose":186.41,"prevQuarterClose":190.19,"fiveDayClose":213.56,"twentyDayClose":186.41,"sixtyDayClose":167.5},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/IBB\",params:#limit:5,,,undefined,":[{"date":"2026-06-15","symbol":"IBB","amount":0.023774,"announcedDate":"2026-06-12","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2026-06-15","defaultRemindTime":1781530200000,"name":"生物科技指数ETF-iShares Nasdaq","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2026-06-18","payableDate":"2026-06-15","currency":"USD","dateTimestamp":1781496000000,"payDate":"2026-06-18"},{"date":"2026-03-17","symbol":"IBB","amount":0.121818,"announcedDate":"2026-03-16","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2026-03-17","defaultRemindTime":1773754200000,"name":"生物科技指数ETF-iShares Nasdaq","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2026-03-20","payableDate":"2026-03-17","currency":"USD","dateTimestamp":1773720000000,"payDate":"2026-03-20"},{"date":"2025-12-16","symbol":"IBB","amount":0.183099,"announcedDate":"2025-12-15","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-12-16","defaultRemindTime":1765895400000,"name":"生物科技指数ETF-iShares Nasdaq","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-12-19","payableDate":"2025-12-16","currency":"USD","dateTimestamp":1765861200000,"payDate":"2025-12-19"},{"date":"2025-09-16","symbol":"IBB","amount":0.082843,"announcedDate":"2025-09-15","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-09-16","defaultRemindTime":1758029400000,"name":"生物科技指数ETF-iShares Nasdaq","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-09-19","payableDate":"2025-09-16","currency":"USD","dateTimestamp":1757995200000,"payDate":"2025-09-19"},{"date":"2025-03-18","symbol":"IBB","amount":0.121169,"announcedDate":"2025-03-17","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-03-18","defaultRemindTime":1742304600000,"name":"生物科技指数ETF-iShares Nasdaq","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-03-21","payableDate":"2025-03-18","currency":"USD","dateTimestamp":1742270400000,"payDate":"2025-03-21"}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"IBB\",market:\"US\",,,undefined,":[{"executeDate":"2016-09-26","recordDate":"2016-09-28","paymentDate":"2016-09-30","value":0.0858219,"currency":"USD"},{"executeDate":"2016-12-22","recordDate":"2016-12-27","paymentDate":"2016-12-29","value":0.091903,"currency":"USD"},{"executeDate":"2017-03-24","recordDate":"2017-03-28","paymentDate":"2017-03-30","value":0.29898,"currency":"USD"},{"executeDate":"2017-06-27","recordDate":"2017-06-29","paymentDate":"2017-06-30","value":0.176803,"currency":"USD"},{"executeDate":"2017-09-26","recordDate":"2017-09-27","paymentDate":"2017-09-29","value":0.118654,"currency":"USD"}],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"IBB\",market:\"US\",delay:false,,,undefined,":{},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"IBB\",pageSize:20,pageCount:5,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2661271017","title":"Renalytix Discloses Director’s Link to Trellus Administration as KidneyIntelX Rollout Advances","url":"https://stock-news.laohu8.com/highlight/detail?id=2661271017","media":"TIPRANKS","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2661271017?lang=en_us&edition=fundamental","pubTime":"2026-08-24 21:42","pubTimestamp":1787578963,"startTime":"0","endTime":"0","summary":"Renalytix ( ($GB:RENX) ) has issued an update. Renalytix plc, a London- and New York-based precision medicine diagnostics group, specializes in art...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/renalytix-discloses-directors-link-to-trellus-administration-as-kidneyintelx-rollout-advances?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/renalytix-discloses-directors-link-to-trellus-administration-as-kidneyintelx-rollout-advances?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["MEDX","FDIF","BK4585","BMED","JDOC","SYNB","HELX","IDNA","WDNA","XT","GNOM","BK4588","GNMX","HTEC","PBE","LFSC","GDOC","TMAT","IBB"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2661271512","title":"Political and General News Events from August 24","url":"https://stock-news.laohu8.com/highlight/detail?id=2661271512","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2661271512?lang=en_us&edition=fundamental","pubTime":"2026-08-24 21:19","pubTimestamp":1787577552,"startTime":"0","endTime":"0","summary":"DIARY-Political and General News Events from August 24Aug 24 (Reuters)-For other diaries, please see:Political andGeneral NewsPOL/DIARYTop Economic EventsM/DIARYEmerging Markets Economic EventsEMRG/DI","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260824:nL4N44L0XV:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1983299246.USD","LU0320765992.SGD","BK4534","LU1023059063.AUD","LU0058720904.USD","LU0122379950.USD","IE0002141913.USD","IE00B4R5TH58.HKD","IBBQ","BK4599","LU2468319806.SGD","PJP","BK4585","BK4588","IE0009355771.USD","LU0289739699.SGD","LU1057294990.SGD","SG9999001440.SGD","LU0889565916.HKD","BK4533","LU2242652126.USD","AMGN","LU2242646821.SGD","IE00BJJMRZ35.SGD","PBE","LU2089984988.USD","TBXU","LU1061106388.HKD","BBH","BK4139","BK4581","IBB","IE00BJT1NW94.SGD","LU0868494617.USD","LU2112291526.USD","IE00BFTCPJ56.SGD","IE00B2B36J28.USD","LU1571399168.USD","BIB","LU0109394709.USD","BK4566"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2661572271","title":"Exchange-Traded Funds, Equity Futures Fall Pre-Bell Monday as Investors Await Details on US Sanctions Against Iran","url":"https://stock-news.laohu8.com/highlight/detail?id=2661572271","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2661572271?lang=en_us&edition=fundamental","pubTime":"2026-08-24 21:19","pubTimestamp":1787577548,"startTime":"0","endTime":"0","summary":"The broad market exchange-traded fund SPDR S&P 500 ETF Trust (SPY) was down 0.2% and the actively traded Invesco QQQ Trust (QQQ) was 0.6% higher in Monday's premarket activity as investors await detai","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BABA","GLD","IYE","FDN","XRT","EETH","IGM","JBLU","VHT","BITO",".IXIC","XLV","USO","EEM","UNG","AEG","IYJ","ISBC","VHT.AU","RTH.AU","E","UAL","FAZ","IBB","EQR","IYH","SLV","BETH","XLF","SOXX","XLP","XLE","VIS","XLY","XSD","PSN","IYW","XLK","FAS","AEG.AU","RTH","SPY.AU","IVV","SPY","GSK","IYK","EXI","XLI","VDC","QQQ"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2661027977","title":"Morning Movers: Regenxbio sinks following clinical hold on RGX-121","url":"https://stock-news.laohu8.com/highlight/detail?id=2661027977","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2661027977?lang=en_us&edition=fundamental","pubTime":"2026-08-24 21:00","pubTimestamp":1787576424,"startTime":"0","endTime":"0","summary":"Stock futures are pointing to a weaker open as the market comes off a losing week for all three major indexes, with technology stocks particularly ...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/morning-movers-regenxbio-sinks-following-clinical-hold-on-rgx-121-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/morning-movers-regenxbio-sinks-following-clinical-hold-on-rgx-121-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["XLK","RGNX","SYNB","BK4505","BK4563","BK4588","TEK","BK4139","IBB","BK4585"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2661279439","title":"Sector Update: Healthcare","url":"https://stock-news.laohu8.com/highlight/detail?id=2661279439","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2661279439?lang=en_us&edition=fundamental","pubTime":"2026-08-24 20:58","pubTimestamp":1787576324,"startTime":"0","endTime":"0","summary":"Healthcare stocks were mixed pre-bell Monday, with the State Street Health Care Select Sector SPDR ETF  0.4% higher and the iShares Biotechnology ETF  down 0.2%,Guardant Health  lost a $245.2 million patent infringement lawsuit filed by TwinStrand Biosciences and the University of Washington, TwinStrand said. Guardant Health stock was down more than 1% premarket.","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["GH","LU1894683264.USD","BK4535","BK4550","LU1894683348.USD","IE00BGHQF748.EUR","IE00B64PRP62.GBP","HELX","BK4585","BK4137","PTH","LU0109394709.USD","LABU","GDOC","EKG","LU1883839398.USD","LU0320765992.SGD","LU0029874061.USD","GNMX","HCSG","FFOX","BK4135","BK4588","IE0034235188.USD","IE00B3QW5Z07.USD","LU0889565916.HKD","STT","XBI","IBB","LU0061475181.USD","XLV","GNOM","BK4551","BK4581","LFSC","LU0128526141.USD","FDN","BK4196"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2661427969","title":"Liminatus Pharma Engages Synex as Contract Research Organization to Support Phase 1/2a Clinical Development of CD19xCD22 bivalent CAR-T therapy","url":"https://stock-news.laohu8.com/highlight/detail?id=2661427969","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2661427969?lang=en_us&edition=fundamental","pubTime":"2026-08-24 20:00","pubTimestamp":1787572800,"startTime":"0","endTime":"0","summary":"Engagement advances clinical execution of IBC101, Liminatus’ CD19xCD22 bivalent CAR-T therapy for relapsed or refractory B-cell malignanciesFULLERTON, Calif., Aug.  24, 2026 (GLOBE NEWSWIRE) -- Limina","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/08/24/3349673/0/en/liminatus-pharma-engages-synex-as-contract-research-organization-to-support-phase-1-2a-clinical-development-of-cd19xcd22-bivalent-car-t-therapy.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4230","SYNB","BK4022","BK4588","IBB","BK4585","CAR"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2661627309","title":"Regenxbio reports FDA placed clinical hold on RGX-121","url":"https://stock-news.laohu8.com/highlight/detail?id=2661627309","media":"TIPRANKS","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2661627309?lang=en_us&edition=fundamental","pubTime":"2026-08-24 19:20","pubTimestamp":1787570406,"startTime":"0","endTime":"0","summary":"Regenxbio (RGNX) provided an update on its investigational gene therapy, RGX-121, for the treatment of Mucopolysaccharidosis type II, also known as...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/regenxbio-reports-fda-placed-clinical-hold-on-rgx-121-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/regenxbio-reports-fda-placed-clinical-hold-on-rgx-121-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["SYNB","CNCR","RGNX","LABU","LFSC","BK4563","BK4588","TBXU","BK4585","GNOM","BK4139","FBT","IBBQ","BK4505","IBB"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2661278374","title":"EU Commission Approves Gilead Trodelvy-Keytruda Combo for First-Line PD-L1+ Metastatic TNBC","url":"https://stock-news.laohu8.com/highlight/detail?id=2661278374","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2661278374?lang=en_us&edition=fundamental","pubTime":"2026-08-24 18:31","pubTimestamp":1787567503,"startTime":"0","endTime":"0","summary":"EU Commission approves Gilead Trodelvy-Keytruda combo for first-line PD-L1+ metastatic TNBCEuropean Commission granted marketing authorization for Trodelvy with Merck’s Keytruda in first-line metastat","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260824:nNDL4gZS8y:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BMED","LU1585245621.USD","LU2357627491.SGD","LU0289739699.SGD","LU2468319806.SGD","BK4566","LU1037948897.HKD","LU1934455277.USD","LU0114720955.EUR","LU0320765992.SGD","LU0109394709.USD","LU1934455194.USD","IBB","BK4585","LU0859254822.USD","LU0965509283.SGD","TBXU","LU1037948541.HKD","LU0823416689.USD","LU1430594728.SGD","SG9999015978.USD","LU1061106388.HKD","LU1674673691.USD","GILD","LU0058720904.USD","SG9999015952.SGD","LU1066051498.USD","IE00B19Z3581.USD","LU1571399168.USD","SG9999015986.USD","BK4550","LU1934455863.HKD","LU0965509010.AUD","BBH","IE00B3T34201.USD","LU0861579265.USD","LU0882574055.USD","LU1023059063.AUD","LU2089984988.USD","BIB","IE00BZ1G4Q59.USD","MEDI","BK4583","LU1778281490.HKD","IBBQ","LU1057294990.SGD","TMED","LU0965508806.USD","IE0002270589.USD","LU0965509101.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2661325278","title":"Gilead - EU Grants Marketing Authorization for Trodelvy with Keytruda in First-Line Pd-L1-Positive Metastatic Tnbc","url":"https://stock-news.laohu8.com/highlight/detail?id=2661325278","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2661325278?lang=en_us&edition=fundamental","pubTime":"2026-08-24 18:31","pubTimestamp":1787567460,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260824:nTUAMP4X3:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["LU0320765992.SGD","GILD","LU1934455194.USD","LU1066051498.USD","BK4139","LU2324357040.USD","LU0965509010.AUD","TBXU","BK4585","IE00B7SZLL34.SGD","LU1839511570.USD","LU1674673691.USD","LU0889565916.HKD","BBH","IBBQ","SG9999015952.SGD","IE00B3T34201.USD","LU1057294990.SGD","IE00B19Z3B42.SGD","BIB","SG9999015986.USD","MEDI","BK4568","LU1037948897.HKD","LU0965509101.SGD","BMED","LU0965509283.SGD","LU1934455863.HKD","BK4566","IE0002270589.USD","LU0965508806.USD","IE00BSNM7G36.USD","LU1585245621.USD","IE00BZ1G4Q59.USD","SG9999015978.USD","LU2357627491.SGD","LU1934455277.USD","BK4550","BK4588","LU1066053197.SGD","LU2468319806.SGD","LU0234570918.USD","LU1674673428.USD","IBB","LU0289739699.SGD","LU1023059063.AUD","LU0058720904.USD","LU1061106388.HKD","TMED","SG9999015945.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2661278323","title":"European Commission Expands Role of Gilead’s Trodelvy® in First-Line Metastatic Triple-Negative Breast Cancer Across Pd-L1 Status","url":"https://stock-news.laohu8.com/highlight/detail?id=2661278323","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2661278323?lang=en_us&edition=fundamental","pubTime":"2026-08-24 18:31","pubTimestamp":1787567460,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260824:nTUAMP4X3:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["LU0289739699.SGD","LU1057294990.SGD","IBB","BK4583","LU0114720955.EUR","SG9999015986.USD","TBXU","LU1674673428.USD","BMED","LU0320765992.SGD","LU0889565916.HKD","SG9999015945.SGD","SG9999015978.USD","LU0965509101.SGD","BIB","LU2089984988.USD","LU0882574055.USD","BK4532","LU1934455863.HKD","LU0861579265.USD","IE00B19Z3B42.SGD","BBH","BK4566","LU0234570918.USD","BK4585","LU0122379950.USD","LU1037948541.HKD","LU0058720904.USD","IBBQ","BK4568","LU1061106388.HKD","MEDI","LU2087621335.USD","BK4139","LU1037948897.HKD","IE00BKVL7J92.USD","LU2324357040.USD","IE00B7SZLL34.SGD","BK4588","LU0823416689.USD","LU0859254822.USD","GILD","LU1674673691.USD","LU1066053197.SGD","LU1585245621.USD","SG9999015952.SGD","LU0109394709.USD","IE00B19Z3581.USD","TMED","LU2357627491.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2661784220","title":"Analysts Are Bullish on Top Healthcare Stocks: Enliven Therapeutics (ELVN), Argenx Se (ARGX)","url":"https://stock-news.laohu8.com/highlight/detail?id=2661784220","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2661784220?lang=en_us&edition=fundamental","pubTime":"2026-08-24 18:20","pubTimestamp":1787566808,"startTime":"0","endTime":"0","summary":"There’s a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on Enliven Therapeutics (ELVN), Argenx Se (ARGX) and Aq...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-are-bullish-on-top-healthcare-stocks-enliven-therapeutics-elvn-argenx-se-argx-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-are-bullish-on-top-healthcare-stocks-enliven-therapeutics-elvn-argenx-se-argx-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU0823416689.USD","IE0009355771.USD","IBB","IE0034235188.USD","ARGX","IE00BFTCPJ56.SGD","BK4505","IE00BJJMRZ35.SGD","BK4588","LU0889565916.HKD","IE00BJT1NW94.SGD","IE00B4R5TH58.HKD","BK4007","FMED","LU1983260115.SGD","LU0109394709.USD","ELVN","IE00B2B36J28.USD","LU0320765992.SGD","BK4585","LU2324357040.USD","TBXU","IE0002141913.USD","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2661222504","title":"Daiichi Sankyo Names Ken Keller Chief Commercialization Officer, Effective April 2027","url":"https://stock-news.laohu8.com/highlight/detail?id=2661222504","media":"Reuters","labels":["executive","event"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2661222504?lang=en_us&edition=fundamental","pubTime":"2026-08-24 15:00","pubTimestamp":1787554851,"startTime":"0","endTime":"0","summary":"Daiichi Sankyo names Ken Keller chief commercialization officer, effective April 2027Daiichi Sankyo named Ken Keller chief commercialization officer, effective April 1, 2027, to run a new globally int","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260824:nNDLbyMxfX:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive,event","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00B4R5TH58.HKD","BK4533","LU1983299246.USD","LU1057294990.SGD","BK4585","LU1571399168.USD","LU2112291526.USD","BK4534","LU0109394709.USD","BIB","SG9999001440.SGD","LU0289739699.SGD","IBBQ","BK4566","LU0320765992.SGD","TBXU","BBH","LU2242646821.SGD","IE00BJT1NW94.SGD","LU2089984988.USD","IE00B2B36J28.USD","LU1061106388.HKD","IE00BJJMRZ35.SGD","IE0009355771.USD","BK4581","IE00BFTCPJ56.SGD","PJP","AMGN","BK4599","LU0058720904.USD","BK4588","LU0889565916.HKD","IE0002141913.USD","LU1023059063.AUD","PBE","BK4139","LU0122379950.USD","LU2242652126.USD","LU2468319806.SGD","LU0868494617.USD","IBB"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2661228075","title":"Is Viavi Solutions (VIAV) Quietly Recasting Its 6G Moat With the Vertex 6.0 Launch?","url":"https://stock-news.laohu8.com/highlight/detail?id=2661228075","media":"Simply Wall St.","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2661228075?lang=en_us&edition=fundamental","pubTime":"2026-08-24 11:29","pubTimestamp":1787542174,"startTime":"0","endTime":"0","summary":"Earlier in August 2026, VIAVI Solutions launched Vertex 6.0, an enhanced channel emulation platform with 400 MHz instantaneous bandwidth and support for carrier frequencies up to 23.6 GHz, targeting next-generation 6G and Wi‑Fi 7/8 testing and integrating real-world RF propagation into lab environments.\nThis upgrade, the first since acquiring Spirent’s high-speed Ethernet, network security and channel emulation testing business, positions Vertex 6.0 as a modular RF digital twin platform...","market":"nz","thumbnail":"https://images.simplywall.st/asset/industry/8111000-choice1-main-header/1585186745276","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/8111000-choice1-main-header/1585186745276"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/tech/nasdaq-viav/viavi-solutions/news/is-viavi-solutions-viav-quietly-recasting-its-6g-moat-with-t","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/tech/nasdaq-viav/viavi-solutions/news/is-viavi-solutions-viav-quietly-recasting-its-6g-moat-with-t","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["VTHR","VIAG","LU0432979614.USD","BIB","AIPO","GNMX","LU2065171311.SGD","IDNA","LU2089984988.USD","LU0109394709.USD","IBB","SG9999013999.USD","VIAV","AGIX","LU0417517546.SGD","LU1674673428.USD","CHAT","VERX","LU0061475181.USD","LU0889565916.HKD","BK4023","IE00B4R5TH58.HKD","LU1585245621.USD","LU2417539215.USD","LU0234570918.USD","BBH","VRTX","ARTY","LU1069344957.HKD","LU0240877869.USD","LU2236285917.USD","LU2065170008.USD","BK4585","IE0002141913.USD","BK4588","LU1093756325.SGD","SG9999001176.SGD","LU0205194284.USD","TBXU","LU2065171402.SGD","LU2362540622.SGD","LU2462157665.USD","PBE","BK4567","QTOC","BK4532","IBBQ","IE00B2B36J28.USD","IE00B19Z9Z06.USD","LU1559883803.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1106379915","title":"ETF Weekly | ETHU Jumps 62%; NUGT Climbs 29%; SMST, MSTZ Sink 45%; Crypto Leverage Sets the Pace","url":"https://stock-news.laohu8.com/highlight/detail?id=1106379915","media":"ETF Weekly","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1106379915?lang=en_us&edition=fundamental","pubTime":"2026-08-23 08:08","pubTimestamp":1787443733,"startTime":"0","endTime":"0","summary":"Market OverviewFor the week of Aug 17–Aug 21, 2026, the Dow Jones Industrial Average fell 0.85%, the S&P 500 declined 1.43%, and the Nasdaq Composite dropped 2.05%.ETF market breadth tilted risk-on,...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"1b73ff2cc9bf460e9cf84e18c58740f6","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["TQQQ","CONX","HXC","BTGD","COIX","GBUG","PICK","CBTA","ETHU","07568","BK4614","CBOO","82823","FXI","MSST","SGXZ99366536.SGD","ESK","ETQ","CQQQ","BRRR","GDXD","NAPR","BK4582","CBTY","CBOY","ETHW","NOCT","SHNY","TMF","CRPT","MSTZ","COII","COIO","EMLC","IBB","XBI","BK4207","XPP","07266","BK4504","GDX.AU","BITX","ARKY","CONL","QDEC","SLV","ETHV","US6M.BOND","QQQX","SGXZ51526630.SGD","GOLY","ICOI","1OZmain","ETHE","IBIT","IMST","CBOJ","DULL","IWM","FEMB","QLD","ETHI","ETHT","GDXU","ETH","QID","BITY","07799","BTCI","MAXI","IAUI","PSQ","03034","US2Y.BOND","USG","UYM","CBXA","EBND.AU","PPI","ARKB","FDN","09834","BK4585","BGLD","GDXY","ASHS","GBTC","02834","BTCL","XBTY","EZBC","JDST","BK4550","HODL","07261","SBIT","XME","ETU","DZZ","02843","03086","82822","ETTY","FLCH","US7Y.BOND","BITO","SGDM","BAR","MSTC","BCCC","BK4581","ETHA","BTFX","MSTU","BETH","MSTK","LABU","EBND","GLDY","MSTX","IAU","BK4593","BFAP","CBXY","KWEB","DUST","GLD","OUNZ","DRAG","JNUG","BITU","AMLX","GLDM","ASHR","WNTR","YINN","ETCO","FBTC","MTYY","SGXZ81514606.USD","METHmain","TZA","XLV","YXI","BPI","MRNY","STCE","BTF","DEFI","EETH","US5Y.BOND","COIG","US30Y.BOND","BTC","MRNX","USSX","KGLD","US12M.BOND","07399","BEGS","CBTO","BK4601","TQQY","CONI","DFII","MSII","RING","UGL","UWM","CBOA","BK4570","BTRN","DGP","BK4535","EZET","FGDL","BK4007","GPIQ","TLTW","BK4588","CEF","MSTY","YANG","82843","09086","GDXJ","NJAN","QMAR","SIVR","VTWO","AAAU","IAUM","FIAT","GLTR","FLTR","IGLD","TWM","QQQM","MSTP","YBTC","BTCC","DGZ","BAGY","SOXS","GDX","QQQ","TLT","US10Y.BOND","SOXL","MNRS","GLL","CBXO","AETH","CBXJ","LEMB","03455","02822","COIW","BTCZ","CHAU","AGQ","MSDD","02823","SMST","US3Y.BOND","BFJL","YETH","ERX","NCIQ","ETHD","SGOL","MST","DBC","TNA","COYY","BTCW","NUGT","QBF","RWM","CBTJ","MOO","COIA","CWEB","BETE","GDXW","MCHI","FXP","NJUL","02840","GOAU","TETH","BITB","BITI","BTCO","MSOO","CONY","ZSL","YGLD","FETH","SQQQ","SETH","URTY","PHYS","07522","QETH","MSTW"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2661302215","title":"Regeneron Pharmaceuticals (REGN) Wins Pasatru Approval, Is The Upside Already Priced In?","url":"https://stock-news.laohu8.com/highlight/detail?id=2661302215","media":"Simply Wall St.","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2661302215?lang=en_us&edition=fundamental","pubTime":"2026-08-22 09:30","pubTimestamp":1787362233,"startTime":"0","endTime":"0","summary":"Regeneron Pharmaceuticals (REGN) stock moved after the U.S. Food and Drug Administration approved Pasatru for adults with fibrodysplasia ossificans progressiva. This new rare disease therapy is supported by late stage OPTIMA trial data.\nSee our latest analysis for Regeneron Pharmaceuticals.\nThe Pasatru approval comes after a strong run in Regeneron Pharmaceuticals’ stock, with a 30.55% 90 day share price return and a 42.21% 1 year total shareholder return, suggesting recent momentum after...","market":"nz","thumbnail":"https://images.simplywall.st/asset/company-cover/33715-main-header/1756202993919","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/company-cover/33715-main-header/1756202993919"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-regn/regeneron-pharmaceuticals/news/regeneron-pharmaceuticals-regn-wins-pasatru-approval-is-the","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-regn/regeneron-pharmaceuticals/news/regeneron-pharmaceuticals-regn-wins-pasatru-approval-is-the","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["LU0058720904.USD","LU2362541513.USD","BK4139","LU2089984988.USD","LU0289739699.SGD","REGN","LU0823434583.USD","LU0053666078.USD","LU2362541273.HKD","BK4588","IBBQ","BBH","TBXU","LU0114720955.EUR","LU2362540622.SGD","LU0882574055.USD","LU2468319806.SGD","LU0109394709.USD","LU2237438978.USD","BK4585","LU2106854487.HKD","LU0823416689.USD","LU2023250504.SGD","LU0823434740.USD","LU0889565916.HKD","DCF","IBB","LU1974910355.USD","LU0320765992.SGD","LU1917777945.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2661213210","title":"Funds: What a Top Biotech Fund is Buying Now","url":"https://stock-news.laohu8.com/highlight/detail?id=2661213210","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2661213210?lang=en_us&edition=fundamental","pubTime":"2026-08-22 09:30","pubTimestamp":1787362200,"startTime":"0","endTime":"0","summary":"It's hard to find a more experienced biotech investor than Evan McCulloch. The manager of Franklin Biotechnology Discovery has been running the $1.2 billion fund since 1997.That matters in this highly","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2089984988.USD","REGN","LU1093756325.SGD","SG9999013999.USD","LU0859254822.USD","BIB","IBBQ","BK4568","LU0154245673.USD","SG9999001440.SGD","BBH","LU1430594728.SGD","IE00B894F039.SGD","LU0882574055.USD","LU2468319806.SGD","BK4583","LU0868494617.USD","LU1983299246.USD","IE00B4R5TH58.HKD","PBE","BK4585","SG9999001176.SGD","IE0002270589.USD","LU2324357040.USD","SG9999015952.SGD","SG9999015986.USD","IE00BSNM7G36.USD","LU1571399168.USD","LU0058720904.USD","BMED","LU0965509101.SGD","MEDI","LU2357627491.SGD","BK4139","IE00B19Z9Z06.USD","LU0823434583.USD","BK4581","XBI","LU1674673691.USD","LU0053666078.USD","LU1934455863.HKD","LU2362541273.HKD","LU0061475181.USD","BK4588","IE00BFTCPJ56.SGD","IDNA","BK4567","LU2087621335.USD","LU2462157665.USD","LU1023059063.AUD","IE00BZ1G4Q59.USD","LU2362540622.SGD","SG9999015978.USD","GILD","LU1061106388.HKD","LU1057294990.SGD","SGXZ57979304.SGD","LU0823434740.USD","LU2242646821.SGD","PJP","BK4578","IBB","LU1069344957.HKD","LU1974910355.USD","IE00B19Z9P08.USD","LU1037948897.HKD","LU0154245756.USD","IE00B2B36J28.USD","LU0965509283.SGD","IE00B19Z3B42.SGD","LU0122379950.USD","BK4534","LU0289739699.SGD","LU1934455194.USD","LU1778281490.HKD","LU1066051498.USD","SG9999015945.SGD","IE0002141913.USD","LU1037948541.HKD","BK4550","LU0256863811.USD","SG9999001176.USD","BK4532","IE00BN0W2V16.EUR","LU0965509010.AUD","LU2417539215.USD","LU1066053197.SGD","LU2106854487.HKD","LU2023250504.SGD","LU0432979614.USD","TMED","BK4599","LU1585245621.USD","LU1917777945.USD","IE00BN0W2W23.USD","AMGN","LU2242652126.USD","IE00B19Z3581.USD","LU2362541513.USD","IE00B7SZLL34.SGD","LU2456880835.USD","IE00B3T34201.USD","LU1934455277.USD","IE00BJT1NW94.SGD","IE00BKVL7J92.USD","IE0009355771.USD","IE00BJJMRZ35.SGD","BK4533","BK4566","IE00BN0W2T93.GBP","LU0861579265.USD","LU0417517546.SGD","JAZZ","LU1093756168.USD","LU1035775433.USD","VRTX","BK4007","LU0079474960.USD","LU2112291526.USD","TBXU","LU0114720955.EUR","LU0965508806.USD","LU0109394709.USD","04332","IE00BZ9MQY76.HKD","LU1839511570.USD","LU2237438978.USD","LU1674673428.USD","LU0823416689.USD","LU0889565916.HKD","LU2236285917.USD","GNMX","LU0234570918.USD","LU0320765992.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2661187372","title":"Gilead Director Jeffrey Bluestone Disposes of 5,000 Common Shares Worth $727,333.60","url":"https://stock-news.laohu8.com/highlight/detail?id=2661187372","media":"Reuters","labels":["shareholding","insiderTrades"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2661187372?lang=en_us&edition=fundamental","pubTime":"2026-08-22 07:22","pubTimestamp":1787354576,"startTime":"0","endTime":"0","summary":"Gilead director Jeffrey Bluestone disposes of 5,000 common shares worth $727,333.60Gilead director Jeffrey Bluestone exercised stock options on Aug. 20, 2026, acquiring 5,000 shares at USD 61.35 to US","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260821:nNDL4cgVd7:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"Gilead Director Jeffrey Bluestone Disposes of 5,000 Common Shares Worth $727,333.60","news_tag":"shareholding,insiderTrades","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2357627491.SGD","SG9999015978.USD","LU2087621335.USD","LU1057294990.SGD","IE00B19Z3B42.SGD","LU2468319806.SGD","LU1778281490.HKD","LU0965509101.SGD","LU0882574055.USD","LU0965508806.USD","BK4583","IBB","LU0859254822.USD","LU0965509010.AUD","LU1934455863.HKD","TBXU","LU1585245621.USD","IE00B3T34201.USD","LU1430594728.SGD","MEDI","LU0289739699.SGD","LU0234570918.USD","LU0320765992.SGD","SG9999015986.USD","LU1571399168.USD","LU1674673428.USD","SG9999015952.SGD","GILD","BK4588","BMED","BK4568","LU1023059063.AUD","LU0122379950.USD","LU0058720904.USD","LU0861579265.USD","LU2089984988.USD","BIB","IE00B7SZLL34.SGD","BK4139","IBBQ","IE00BSNM7G36.USD","LU0965509283.SGD","BK4532","LU1066053197.SGD","LU1674673691.USD","TMED","IE00B19Z3581.USD","SG9999015945.SGD","BK4566","BBH"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2661972042","title":"Moderna Inc. Stock Advances 8.9%, Outperforms Peers","url":"https://stock-news.laohu8.com/highlight/detail?id=2661972042","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2661972042?lang=en_us&edition=fundamental","pubTime":"2026-08-22 04:33","pubTimestamp":1787344380,"startTime":"0","endTime":"0","summary":"This article was automatically generated by Dow Jones using technology from Automated Insights.Shares of Moderna Inc. rose 8.9% to $145.13 on what proved to be an all-around favorable trading session for the stock market, with the NASDAQ Composite Index rising 0.4% to 26,180.45 and the Dow Jones Industrial Average rising 1.0% to 53,277.01.Moderna Inc. closed 17.8% below its 52-week high of $176.66, which the company reached on August 19th.The stock outperformed some of its peers, as Johnson & Johnson rose 1.1% to $270.24, Pfizer Inc. rose 1.0% to $28.07, and Gilead Sciences Inc. rose 1.87% to $146.12.Trading volume totaled 86.7 million, compared to the 50-day average of 13.0 million.Data source: Dow Jones Market Data, FactSet","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["GILD","LU0320765992.SGD","LU1839511570.USD","LU1430594728.SGD","LU1037948541.HKD","IDNA","LU0289739699.SGD","IBBQ","LGHT","LU1585245621.USD","LU0234570918.USD","LU1571399168.USD","BK4550","LU0122379950.USD","TBXU","LU1061106388.HKD","IE0002270589.USD","TMED","SG9999015978.USD","MEDI","BK4585","MRNX","BK4501","LU1057294990.SGD","BIB","LU0965509283.SGD","LU0861579265.USD","SG9999015952.SGD","LU2324357040.USD","WDNA","LU1934455863.HKD","BK4583","MRNA","BK4532","LU1674673691.USD","BBH","LU0965508806.USD","IBB","LU0058720904.USD","LU0823416689.USD","SG9999015986.USD","LU2357627491.SGD","LU1066053197.SGD","BK4551","LU1934455194.USD","GNOM","LU2112291526.USD","MRNY","BMED","LU0965509010.AUD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2661940352","title":"Gilead Declares Q3 2026 Dividend of R$ 0.24 Per Unit","url":"https://stock-news.laohu8.com/highlight/detail?id=2661940352","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2661940352?lang=en_us&edition=fundamental","pubTime":"2026-08-22 01:58","pubTimestamp":1787335117,"startTime":"0","endTime":"0","summary":"Gilead declares Q3 2026 dividend of R$ 0.24 per unitGilead Sciences set a Q3 2026 distribution of R$ 0.24 per unit for BRGILDBDR 000.Last day to trade with rights: Sept. 11, 2026.Payment date: Oct. 5,","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260821:nNDL12Yy9R:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["MEDI","TBXU","LU0889565916.HKD","BBH","GILD","BK4532","LU0965509283.SGD","IE00BSNM7G36.USD","IBBQ","IE00B19Z3B42.SGD","LU1061106388.HKD","LU0122379950.USD","LU0320765992.SGD","BK4568","IE00B3T34201.USD","LU1430594728.SGD","IE00BKVL7J92.USD","LU0965509101.SGD","BK4578","LU0882574055.USD","IBB","LU1066053197.SGD","LU0823416689.USD","LU1674673428.USD","LU2357627491.SGD","BK4585","LU2112291526.USD","LU0114720955.EUR","LU1037948541.HKD","BK4139","SG9999015986.USD","BK4583","LU0859254822.USD","IE00B7SZLL34.SGD","LU2324357040.USD","LU2089984988.USD","BK4550","BIB","LU1585245621.USD","LU0965508806.USD","LU2468319806.SGD","BK4588","BMED","LU1037948897.HKD","IE0002270589.USD","LU0965509010.AUD","SG9999015952.SGD","LU1674673691.USD","TMED","LU1023059063.AUD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2661887294","title":"Amgen Advances Tarlatamab Shot vs. Infusion in Phase 3 Lung Cancer Study","url":"https://stock-news.laohu8.com/highlight/detail?id=2661887294","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2661887294?lang=en_us&edition=fundamental","pubTime":"2026-08-22 00:34","pubTimestamp":1787330049,"startTime":"0","endTime":"0","summary":"Amgen Inc ($AMGN) announced an update on their ongoing clinical study. Amgen’s new Phase 3 DeLLphi-315 study tests its cancer drug tarlatamab in pe...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/amgen-advances-tarlatamab-shot-vs-infusion-in-phase-3-lung-cancer-study?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/amgen-advances-tarlatamab-shot-vs-infusion-in-phase-3-lung-cancer-study?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["IE0009355771.USD","LU2468319806.SGD","LU1061106388.HKD","LU0122379950.USD","LU2242646821.SGD","LU0058720904.USD","AMGN","LU0889565916.HKD","BIB","LU2242652126.USD","BK4588","PJP","LU1023059063.AUD","LU2112291526.USD","LU0868494617.USD","LU0289739699.SGD","BK4599","IE00BFTCPJ56.SGD","LU0109394709.USD","LU1057294990.SGD","IE00BJT1NW94.SGD","IBB","LU0320765992.SGD","PBE","BBH","IBBQ","IE00B2B36J28.USD","LU1983299246.USD","LU2089984988.USD","TBXU","BK4533","SG9999001440.SGD","BK4566","BK4139","IE0002141913.USD","BK4581","BK4534","BK4585","LU1571399168.USD","IE00BJJMRZ35.SGD","IE00B4R5TH58.HKD"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":10,"pageCount":5,"totalSize":200,"code":"91000000","status":"200"}]}}